No Data
No Data
OptionMetrics and CRSP Announce Partnership Giving Academic Researchers Increased Integration of U.S. Equities and Options Data in Research
CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Press Release: CRISPR Therapeutics Proposes New Appointment to the Board of Directors
BofA Securities Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Cuts Target Price to $85
Crispr Therapeutics Price Target Lowered to $85 From $98 at BofA
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Warren Buffed : no i share losses,daily basis too
102631395 : Me too
ppspirit : Thank you for your honest sharing. Thank you for making me feel I am normal and it is normal to not have good days. As long as these companies are still earning, I think we are safe.
Far Out : I am also a big loser, just recently lost more than half of my positions in ionq and qbet after Jansun Huang made a comment about Quountom computer.